{"entity":{"type":"insider","cik":"0001290165","url":"/insider/0001290165","json_url":"/insider/0001290165.json","name":"QVT Fund LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":84,"n_filings":42,"first":"2009-09-24","last":"2011-10-24","span_basis":"filed_date"},"name_variants":[{"name":"QVT Fund LP","source":"filing","n_filings":42,"first_seen":"2009-09-24","last_seen":"2011-10-24"}],"transactions":[{"id":8888326,"accession":"0001209191-11-052489","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-052489","line_url":"/filing/0001209191-11-052489#line-2","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":364918.0,"shares_display":"364,918","price_per_share":3.68,"price_display":"3.68","price_state":"stated","total_value":1342898.24,"total_display":"1,342,898.24","shares_owned_after":5152936.0,"shares_owned_after_display":"5,152,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-10-21","filed_date":"2011-10-24","scope":"insider"},{"id":8888323,"accession":"0001209191-11-052489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-052489","line_url":"/filing/0001209191-11-052489#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5252700.0,"shares_display":"5,252,700","price_per_share":3.68,"price_display":"3.68","price_state":"stated","total_value":19329936.0,"total_display":"19,329,936.00","shares_owned_after":5517854.0,"shares_owned_after_display":"5,517,854","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-10-20","filed_date":"2011-10-24","scope":"insider"},{"id":8969278,"accession":"0001209191-11-052181","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-052181","line_url":"/filing/0001209191-11-052181#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":650100.0,"shares_display":"650,100","price_per_share":3.68,"price_display":"3.68","price_state":"stated","total_value":2392368.0,"total_display":"2,392,368.00","shares_owned_after":10770554.0,"shares_owned_after_display":"10,770,554","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-10-17","filed_date":"2011-10-19","scope":"insider"},{"id":8911515,"accession":"0001209191-11-049240","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-11-049240","line_url":"/filing/0001209191-11-049240#line-4","is_derivative":false,"issuer_cik":"0001274913","issuer_name":"INHIBITEX, INC.","issuer_ticker":"INHX","issuer_name_source":null,"issuer_url":"/issuer/0001274913","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":600000.0,"total_display":"600,000.00","shares_owned_after":7700662.0,"shares_owned_after_display":"7,700,662","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-09-27","filed_date":"2011-09-28","scope":"insider"},{"id":8911513,"accession":"0001209191-11-049240","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-11-049240","line_url":"/filing/0001209191-11-049240#line-3","is_derivative":false,"issuer_cik":"0001274913","issuer_name":"INHIBITEX, INC.","issuer_ticker":"INHX","issuer_name_source":null,"issuer_url":"/issuer/0001274913","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":89100.0,"total_display":"89,100.00","shares_owned_after":7904562.0,"shares_owned_after_display":"7,904,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-09-26","filed_date":"2011-09-28","scope":"insider"},{"id":8911511,"accession":"0001209191-11-049240","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-049240","line_url":"/filing/0001209191-11-049240#line-2","is_derivative":false,"issuer_cik":"0001274913","issuer_name":"INHIBITEX, INC.","issuer_ticker":"INHX","issuer_name_source":null,"issuer_url":"/issuer/0001274913","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":3.01,"price_display":"3.01","price_state":"stated","total_value":7525.0,"total_display":"7,525.00","shares_owned_after":7900662.0,"shares_owned_after_display":"7,900,662","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-09-26","filed_date":"2011-09-28","scope":"insider"},{"id":8911509,"accession":"0001209191-11-049240","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-049240","line_url":"/filing/0001209191-11-049240#line-1","is_derivative":false,"issuer_cik":"0001274913","issuer_name":"INHIBITEX, INC.","issuer_ticker":"INHX","issuer_name_source":null,"issuer_url":"/issuer/0001274913","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":4340.0,"total_display":"4,340.00","shares_owned_after":7903162.0,"shares_owned_after_display":"7,903,162","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-09-26","filed_date":"2011-09-28","scope":"insider"},{"id":9071136,"accession":"0001181431-11-034497","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-034497","line_url":"/filing/0001181431-11-034497#line-2","is_derivative":false,"issuer_cik":"0001274913","issuer_name":"INHIBITEX, INC.","issuer_ticker":"INHX","issuer_name_source":null,"issuer_url":"/issuer/0001274913","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":4.49,"price_display":"4.49","price_state":"stated","total_value":2694000.0,"total_display":"2,694,000.00","shares_owned_after":7989562.0,"shares_owned_after_display":"7,989,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-31","filed_date":"2011-06-02","scope":"insider"},{"id":9071135,"accession":"0001181431-11-034497","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-034497","line_url":"/filing/0001181431-11-034497#line-1","is_derivative":false,"issuer_cik":"0001274913","issuer_name":"INHIBITEX, INC.","issuer_ticker":"INHX","issuer_name_source":null,"issuer_url":"/issuer/0001274913","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":4.58,"price_display":"4.58","price_state":"stated","total_value":251900.0,"total_display":"251,900.00","shares_owned_after":7934562.0,"shares_owned_after_display":"7,934,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-31","filed_date":"2011-06-02","scope":"insider"},{"id":8985580,"accession":"0001181431-11-023524","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-11-023524","line_url":"/filing/0001181431-11-023524#line-5","is_derivative":false,"issuer_cik":"0001274913","issuer_name":"INHIBITEX, INC.","issuer_ticker":"INHX","issuer_name_source":null,"issuer_url":"/issuer/0001274913","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78335.0,"shares_display":"78,335","price_per_share":4.29,"price_display":"4.29","price_state":"stated","total_value":336057.15,"total_display":"336,057.15","shares_owned_after":8589562.0,"shares_owned_after_display":"8,589,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-04-11","filed_date":"2011-04-11","scope":"insider"},{"id":8985579,"accession":"0001181431-11-023524","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-11-023524","line_url":"/filing/0001181431-11-023524#line-4","is_derivative":false,"issuer_cik":"0001274913","issuer_name":"INHIBITEX, INC.","issuer_ticker":"INHX","issuer_name_source":null,"issuer_url":"/issuer/0001274913","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60717.0,"shares_display":"60,717","price_per_share":4.28,"price_display":"4.28","price_state":"stated","total_value":259868.76,"total_display":"259,868.76","shares_owned_after":8667897.0,"shares_owned_after_display":"8,667,897","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-04-11","filed_date":"2011-04-11","scope":"insider"},{"id":8985578,"accession":"0001181431-11-023524","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-11-023524","line_url":"/filing/0001181431-11-023524#line-3","is_derivative":false,"issuer_cik":"0001274913","issuer_name":"INHIBITEX, INC.","issuer_ticker":"INHX","issuer_name_source":null,"issuer_url":"/issuer/0001274913","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":230000.0,"shares_display":"230,000","price_per_share":4.37,"price_display":"4.37","price_state":"stated","total_value":1005100.0,"total_display":"1,005,100.00","shares_owned_after":8833996.0,"shares_owned_after_display":"8,833,996","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-04-08","filed_date":"2011-04-11","scope":"insider"},{"id":8985577,"accession":"0001181431-11-023524","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-023524","line_url":"/filing/0001181431-11-023524#line-2","is_derivative":false,"issuer_cik":"0001274913","issuer_name":"INHIBITEX, INC.","issuer_ticker":"INHX","issuer_name_source":null,"issuer_url":"/issuer/0001274913","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105382.0,"shares_display":"105,382","price_per_share":4.39,"price_display":"4.39","price_state":"stated","total_value":462626.98,"total_display":"462,626.98","shares_owned_after":8728614.0,"shares_owned_after_display":"8,728,614","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-04-08","filed_date":"2011-04-11","scope":"insider"},{"id":8985576,"accession":"0001181431-11-023524","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-023524","line_url":"/filing/0001181431-11-023524#line-1","is_derivative":false,"issuer_cik":"0001274913","issuer_name":"INHIBITEX, INC.","issuer_ticker":"INHX","issuer_name_source":null,"issuer_url":"/issuer/0001274913","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":129757.0,"shares_display":"129,757","price_per_share":4.52,"price_display":"4.52","price_state":"stated","total_value":586501.64,"total_display":"586,501.64","shares_owned_after":9063996.0,"shares_owned_after_display":"9,063,996","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-04-07","filed_date":"2011-04-11","scope":"insider"},{"id":9001844,"accession":"0001181431-11-002006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-002006","line_url":"/filing/0001181431-11-002006#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34209.0,"shares_display":"34,209","price_per_share":1.41,"price_display":"1.41","price_state":"stated","total_value":48234.69,"total_display":"48,234.69","shares_owned_after":11420654.0,"shares_owned_after_display":"11,420,654","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-01-03","filed_date":"2011-01-05","scope":"insider"},{"id":9014411,"accession":"0001181431-11-001356","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-001356","line_url":"/filing/0001181431-11-001356#line-1","is_derivative":false,"issuer_cik":"0001290165","issuer_name":"TPC Group Inc.","issuer_ticker":"TPCG","issuer_name_source":null,"issuer_url":"/issuer/0001290165","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":30.77,"price_display":"30.77","price_state":"stated","total_value":430780.0,"total_display":"430,780.00","shares_owned_after":2705145.0,"shares_owned_after_display":"2,705,145","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-31","filed_date":"2011-01-04","scope":"insider"},{"id":9140631,"accession":"0001181431-11-000429","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-11-000429","line_url":"/filing/0001181431-11-000429#line-3","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":1.48,"price_display":"1.48","price_state":"stated","total_value":444.0,"total_display":"444.00","shares_owned_after":11386445.0,"shares_owned_after_display":"11,386,445","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-30","filed_date":"2011-01-03","scope":"insider"},{"id":9140630,"accession":"0001181431-11-000429","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-000429","line_url":"/filing/0001181431-11-000429#line-2","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":267014.0,"shares_display":"267,014","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":387170.3,"total_display":"387,170.30","shares_owned_after":11386145.0,"shares_owned_after_display":"11,386,145","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-29","filed_date":"2011-01-03","scope":"insider"},{"id":9140629,"accession":"0001181431-11-000429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-000429","line_url":"/filing/0001181431-11-000429#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.46,"price_display":"1.46","price_state":"stated","total_value":73000.0,"total_display":"73,000.00","shares_owned_after":11119131.0,"shares_owned_after_display":"11,119,131","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-29","filed_date":"2011-01-03","scope":"insider"},{"id":7410259,"accession":"0001181431-10-064096","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-10-064096","line_url":"/filing/0001181431-10-064096#line-3","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":532490.0,"shares_display":"532,490","price_per_share":1.44,"price_display":"1.44","price_state":"stated","total_value":766785.6,"total_display":"766,785.60","shares_owned_after":11069131.0,"shares_owned_after_display":"11,069,131","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-28","filed_date":"2010-12-29","scope":"insider"},{"id":7410256,"accession":"0001181431-10-064096","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-064096","line_url":"/filing/0001181431-10-064096#line-2","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12200.0,"shares_display":"12,200","price_per_share":1.34,"price_display":"1.34","price_state":"stated","total_value":16348.0,"total_display":"16,348.00","shares_owned_after":10536641.0,"shares_owned_after_display":"10,536,641","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-28","filed_date":"2010-12-29","scope":"insider"},{"id":7388173,"accession":"0001181431-10-064095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-064095","line_url":"/filing/0001181431-10-064095#line-2","is_derivative":false,"issuer_cik":"0001290165","issuer_name":"TPC Group Inc.","issuer_ticker":"TPCG","issuer_name_source":null,"issuer_url":"/issuer/0001290165","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24600.0,"shares_display":"24,600","price_per_share":30.78,"price_display":"30.78","price_state":"stated","total_value":757188.0,"total_display":"757,188.00","shares_owned_after":2719145.0,"shares_owned_after_display":"2,719,145","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-28","filed_date":"2010-12-29","scope":"insider"},{"id":7410254,"accession":"0001181431-10-064096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-064096","line_url":"/filing/0001181431-10-064096#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1714210.0,"shares_display":"1,714,210","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":2228473.0,"total_display":"2,228,473.00","shares_owned_after":10524441.0,"shares_owned_after_display":"10,524,441","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-27","filed_date":"2010-12-29","scope":"insider"},{"id":7388169,"accession":"0001181431-10-064095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-064095","line_url":"/filing/0001181431-10-064095#line-1","is_derivative":false,"issuer_cik":"0001290165","issuer_name":"TPC Group Inc.","issuer_ticker":"TPCG","issuer_name_source":null,"issuer_url":"/issuer/0001290165","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49000.0,"shares_display":"49,000","price_per_share":30.85,"price_display":"30.85","price_state":"stated","total_value":1511650.0,"total_display":"1,511,650.00","shares_owned_after":2743745.0,"shares_owned_after_display":"2,743,745","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-27","filed_date":"2010-12-29","scope":"insider"},{"id":7287204,"accession":"0001181431-10-063627","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-063627","line_url":"/filing/0001181431-10-063627#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":285790.0,"shares_display":"285,790","price_per_share":1.21,"price_display":"1.21","price_state":"stated","total_value":345805.9,"total_display":"345,805.90","shares_owned_after":8810231.0,"shares_owned_after_display":"8,810,231","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-23","filed_date":"2010-12-27","scope":"insider"},{"id":7466318,"accession":"0001181431-10-051764","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-051764","line_url":"/filing/0001181431-10-051764#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":247500.0,"total_display":"247,500.00","shares_owned_after":8524441.0,"shares_owned_after_display":"8,524,441","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-20","filed_date":"2010-10-22","scope":"insider"},{"id":7218809,"accession":"0001181431-10-051388","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-10-051388","line_url":"/filing/0001181431-10-051388#line-5","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1951389.0,"shares_display":"1,951,389","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":3512500.2,"total_display":"3,512,500.20","shares_owned_after":8024441.0,"shares_owned_after_display":"8,024,441","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-15","filed_date":"2010-10-19","scope":"insider"},{"id":7218807,"accession":"0001181431-10-051388","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-051388","line_url":"/filing/0001181431-10-051388#line-4","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":247500.0,"total_display":"247,500.00","shares_owned_after":8374441.0,"shares_owned_after_display":"8,374,441","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-15","filed_date":"2010-10-19","scope":"insider"},{"id":7218804,"accession":"0001181431-10-051388","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-10-051388","line_url":"/filing/0001181431-10-051388#line-3","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90000.0,"shares_display":"90,000","price_per_share":1.68,"price_display":"1.68","price_state":"stated","total_value":151200.0,"total_display":"151,200.00","shares_owned_after":8114441.0,"shares_owned_after_display":"8,114,441","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-15","filed_date":"2010-10-19","scope":"insider"},{"id":7218802,"accession":"0001181431-10-051388","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-051388","line_url":"/filing/0001181431-10-051388#line-2","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":85000.0,"shares_display":"85,000","price_per_share":1.66,"price_display":"1.66","price_state":"stated","total_value":141100.0,"total_display":"141,100.00","shares_owned_after":8224441.0,"shares_owned_after_display":"8,224,441","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-15","filed_date":"2010-10-19","scope":"insider"},{"id":7218800,"accession":"0001181431-10-051388","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-051388","line_url":"/filing/0001181431-10-051388#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.67,"price_display":"1.67","price_state":"stated","total_value":41750.0,"total_display":"41,750.00","shares_owned_after":8139441.0,"shares_owned_after_display":"8,139,441","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-15","filed_date":"2010-10-19","scope":"insider"},{"id":7490419,"accession":"0001181431-10-047373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-047373","line_url":"/filing/0001181431-10-047373#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":1.78,"price_display":"1.78","price_state":"stated","total_value":14240.0,"total_display":"14,240.00","shares_owned_after":6073052.0,"shares_owned_after_display":"6,073,052","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-09-16","filed_date":"2010-09-20","scope":"insider"},{"id":7196074,"accession":"0001181431-10-046635","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-046635","line_url":"/filing/0001181431-10-046635#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":45000.0,"total_display":"45,000.00","shares_owned_after":6065052.0,"shares_owned_after_display":"6,065,052","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-09-10","filed_date":"2010-09-14","scope":"insider"},{"id":7325210,"accession":"0001181431-10-045633","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-045633","line_url":"/filing/0001181431-10-045633#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.74,"price_display":"1.74","price_state":"stated","total_value":43500.0,"total_display":"43,500.00","shares_owned_after":6040052.0,"shares_owned_after_display":"6,040,052","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-09-01","filed_date":"2010-09-03","scope":"insider"},{"id":7303379,"accession":"0001181431-10-044955","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-044955","line_url":"/filing/0001181431-10-044955#line-2","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.77,"price_display":"1.77","price_state":"stated","total_value":44250.0,"total_display":"44,250.00","shares_owned_after":6015052.0,"shares_owned_after_display":"6,015,052","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-30","filed_date":"2010-08-31","scope":"insider"},{"id":7303377,"accession":"0001181431-10-044955","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-044955","line_url":"/filing/0001181431-10-044955#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":10500.0,"total_display":"10,500.00","shares_owned_after":5990052.0,"shares_owned_after_display":"5,990,052","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-27","filed_date":"2010-08-31","scope":"insider"},{"id":7176932,"accession":"0001181431-10-044660","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-044660","line_url":"/filing/0001181431-10-044660#line-2","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15700.0,"shares_display":"15,700","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":27475.0,"total_display":"27,475.00","shares_owned_after":5984052.0,"shares_owned_after_display":"5,984,052","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-26","filed_date":"2010-08-27","scope":"insider"},{"id":7176929,"accession":"0001181431-10-044660","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-044660","line_url":"/filing/0001181431-10-044660#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17400.0,"shares_display":"17,400","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":29580.0,"total_display":"29,580.00","shares_owned_after":5968352.0,"shares_owned_after_display":"5,968,352","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-25","filed_date":"2010-08-27","scope":"insider"},{"id":7490227,"accession":"0001181431-10-044156","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-044156","line_url":"/filing/0001181431-10-044156#line-2","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34900.0,"shares_display":"34,900","price_per_share":1.73,"price_display":"1.73","price_state":"stated","total_value":60377.0,"total_display":"60,377.00","shares_owned_after":5950952.0,"shares_owned_after_display":"5,950,952","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-24","filed_date":"2010-08-25","scope":"insider"},{"id":7490225,"accession":"0001181431-10-044156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-044156","line_url":"/filing/0001181431-10-044156#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27000.0,"shares_display":"27,000","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":48330.0,"total_display":"48,330.00","shares_owned_after":5916052.0,"shares_owned_after_display":"5,916,052","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-23","filed_date":"2010-08-25","scope":"insider"},{"id":7710453,"accession":"0001181431-10-043180","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-043180","line_url":"/filing/0001181431-10-043180#line-2","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.77,"price_display":"1.77","price_state":"stated","total_value":7080.0,"total_display":"7,080.00","shares_owned_after":5889052.0,"shares_owned_after_display":"5,889,052","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-20","filed_date":"2010-08-23","scope":"insider"},{"id":7710450,"accession":"0001181431-10-043180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-043180","line_url":"/filing/0001181431-10-043180#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16000.0,"shares_display":"16,000","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":28640.0,"total_display":"28,640.00","shares_owned_after":5885052.0,"shares_owned_after_display":"5,885,052","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-19","filed_date":"2010-08-23","scope":"insider"},{"id":7366276,"accession":"0001181431-10-042474","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-042474","line_url":"/filing/0001181431-10-042474#line-2","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":9000.0,"total_display":"9,000.00","shares_owned_after":5869052.0,"shares_owned_after_display":"5,869,052","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-17","filed_date":"2010-08-18","scope":"insider"},{"id":7366274,"accession":"0001181431-10-042474","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-042474","line_url":"/filing/0001181431-10-042474#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":1.86,"price_display":"1.86","price_state":"stated","total_value":65100.0,"total_display":"65,100.00","shares_owned_after":5864052.0,"shares_owned_after_display":"5,864,052","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-16","filed_date":"2010-08-18","scope":"insider"},{"id":7386847,"accession":"0001181431-10-042009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-042009","line_url":"/filing/0001181431-10-042009#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32500.0,"shares_display":"32,500","price_per_share":1.94,"price_display":"1.94","price_state":"stated","total_value":63050.0,"total_display":"63,050.00","shares_owned_after":5829052.0,"shares_owned_after_display":"5,829,052","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-12","filed_date":"2010-08-16","scope":"insider"},{"id":7423152,"accession":"0001181431-10-040566","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-040566","line_url":"/filing/0001181431-10-040566#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50400.0,"shares_display":"50,400","price_per_share":1.99,"price_display":"1.99","price_state":"stated","total_value":100296.0,"total_display":"100,296.00","shares_owned_after":5796552.0,"shares_owned_after_display":"5,796,552","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-03","filed_date":"2010-08-05","scope":"insider"},{"id":7507519,"accession":"0001181431-10-036968","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-036968","line_url":"/filing/0001181431-10-036968#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Associates GP LLC; QVT Fund LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.98,"price_display":"1.98","price_state":"stated","total_value":59400.0,"total_display":"59,400.00","shares_owned_after":5746152.0,"shares_owned_after_display":"5,746,152","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-07-06","filed_date":"2010-07-08","scope":"insider"},{"id":7284587,"accession":"0001181431-10-036521","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-036521","line_url":"/filing/0001181431-10-036521#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56800.0,"shares_display":"56,800","price_per_share":1.94,"price_display":"1.94","price_state":"stated","total_value":110192.0,"total_display":"110,192.00","shares_owned_after":5716152.0,"shares_owned_after_display":"5,716,152","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-07-02","filed_date":"2010-07-06","scope":"insider"},{"id":7446237,"accession":"0001181431-10-020965","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-020965","line_url":"/filing/0001181431-10-020965#line-1","is_derivative":false,"issuer_cik":"0001290165","issuer_name":"TPC Group Inc.","issuer_ticker":"TPCP","issuer_name_source":null,"issuer_url":"/issuer/0001290165","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock , $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":194490.0,"shares_display":"194,490","price_per_share":12.75,"price_display":"12.75","price_state":"stated","total_value":2479747.5,"total_display":"2,479,747.50","shares_owned_after":2792745.0,"shares_owned_after_display":"2,792,745","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-04-07","filed_date":"2010-04-08","scope":"insider"},{"id":5776182,"accession":"0001181431-09-057762","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-057762","line_url":"/filing/0001181431-09-057762#line-1","is_derivative":false,"issuer_cik":"0001274913","issuer_name":"INHIBITEX, INC.","issuer_ticker":"INHX","issuer_name_source":null,"issuer_url":"/issuer/0001274913","owner_cik":null,"owner_name":"QVT Fund LP; QVT Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43000.0,"shares_display":"43,000","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":36550.0,"total_display":"36,550.00","shares_owned_after":9193753.0,"shares_owned_after_display":"9,193,753","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-16","filed_date":"2009-12-18","scope":"insider"}],"next_cursor":"2009-12-16|5776182","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001128495","name":"ANADYS PHARMACEUTICALS INC","url":"/issuer/0001128495","role":"Ten percent owner","n_filings":20,"first_seen":"2010-07-06","last_seen":"2011-10-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001274913","name":"INHIBITEX, INC.","url":"/issuer/0001274913","role":"Ten percent owner","n_filings":18,"first_seen":"2009-11-03","last_seen":"2011-09-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001452217","name":"TPC Group Inc.","url":"/issuer/0001452217","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2010-04-08","last_seen":"2011-01-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001301081","name":"Pharmasset Inc","url":"/issuer/0001301081","role":"Ten percent owner","n_filings":1,"first_seen":"2009-09-24","last_seen":"2009-09-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001290165","retrieved_at":"2026-08-21T09:03:45+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}